Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) in juvenile and adult dogs

BACKGROUND: The combination of milbemycin oxime (MO) and lotilaner (Credelio(®) Plus) is a novel systemic endectocide that provides month-long effectiveness in dogs after a single oral treatment. The safety of Credelio(®) Plus flavored chewable tablets was investigated in three target animal safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Riggs, Kari L., Wiseman, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161958/
https://www.ncbi.nlm.nih.gov/pubmed/34044853
http://dx.doi.org/10.1186/s13071-021-04760-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161958/
https://www.ncbi.nlm.nih.gov/pubmed/34044853
http://dx.doi.org/10.1186/s13071-021-04760-z

Ejemplares similares